Growth Metrics

Steris (STE) EBITDA Margin (2018 - 2025)

Historic EBITDA Margin for Steris (STE) over the last 8 years, with Q4 2025 value amounting to 18.26%.

  • Steris' EBITDA Margin rose 3600.0% to 18.26% in Q4 2025 from the same period last year, while for Dec 2025 it was 17.18%, marking a year-over-year increase of 10500.0%. This contributed to the annual value of 15.87% for FY2025, which is 4000.0% down from last year.
  • Latest data reveals that Steris reported EBITDA Margin of 18.26% as of Q4 2025, which was up 3600.0% from 18.2% recorded in Q3 2025.
  • In the past 5 years, Steris' EBITDA Margin registered a high of 58.41% during Q1 2023, and its lowest value of 28.09% during Q3 2022.
  • Moreover, its 5-year median value for EBITDA Margin was 16.52% (2021), whereas its average is 15.09%.
  • Per our database at Business Quant, Steris' EBITDA Margin surged by 465100bps in 2023 and then tumbled by -428800bps in 2024.
  • Quarter analysis of 5 years shows Steris' EBITDA Margin stood at 16.79% in 2021, then grew by 2bps to 17.15% in 2022, then rose by 2bps to 17.45% in 2023, then grew by 3bps to 17.9% in 2024, then increased by 2bps to 18.26% in 2025.
  • Its last three reported values are 18.26% in Q4 2025, 18.2% for Q3 2025, and 17.68% during Q2 2025.